Apogee 8K Filing
Apogee Therapeutics files 8K with SEC, disclosing other events and financial statements. The filing may contain material information for investors.
Filed: 2026-05-27 AccNo: 0001104659-26-066572 Size: 8 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits